"We believe one of the biggest questions on investors' minds is can [they] grow FY14 earnings,"...
May 14 2013, 10:02 ET
"We believe one of the biggest questions on investors' minds is can [they] grow FY14 earnings," says Jefferies, stating what might fairly be called "the obvious" in a note upgrading WellPoint (WLP +1.5%) to Buy from Hold and raising the stock's price target to $92. After a "deep dive" analysis, the investment bank says it sees 7-8% EPS growth against the Street's 2.4% consensus and predicts $8.61 per share for FY14, making WLP the cheapest MCO stock, trading at 8.8x forward earnings. Meanwhile, Cigna (CI -1.8%) is "ready for a breather" and catches a downgrade to Hold from Buy — CI's CFO Ralph Nicoletti announced Monday he is leaving the company for personal reasons.